Clinical Trials Logo

Clinical Trial Summary

This is a prospective, multicenter, randomized, controlled, two-arm, non-inferiority study which will be conducted in China to support registration of a cephalomedullary nailing system (TFNA) that currently is available globally. The study will compare the safety and the effectiveness of two intramedullary nails (the investigational group is TFNA and the control group is PFNA-II).Patients enrolled at each site will be randomized in a ratio of 1:1, i.e. one patient assigned to surgery implanted with TFNA for each patient assigned to PFNA-II. Separate block randomization schedules within each site will be used to ensure equal distribution of treatment and control patients. Up to 15 centers will be approved to participate in this study. Patient will be clinically followed after surgery at 1, 6, 12 and 24 weeks. The data up to and including 24 week follow up visit will be used in determining the primary safety and effectiveness of the TFNA. The primary objective of this study is to evaluate whether fracture union rate, evaluated 24 weeks after proximal femur fracture, for the investigational TFNA intramedullary nail is non-inferior to that for currently available control product PFNA-II in patients with proximal femur fractures.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03635320
Study type Interventional
Source Synthes GmbH
Contact
Status Completed
Phase N/A
Start date December 13, 2018
Completion date May 18, 2020

See also
  Status Clinical Trial Phase
Recruiting NCT01354535 - Types of Fixation of Vancouver B1 Periprosthetic Fractures N/A
Completed NCT02267330 - Gonadal Radiation Exposure and Risk Secondary to Fluoroscopic Imaging During Trauma Surgery